Immune Netw.  2015 Dec;15(6):325-330. 10.4110/in.2015.15.6.325.

Effect of Ixeris dentata Nakai Extract on Nitric Oxide Production and Prostaglandin E2 Generation in LPS-stimulated RAW264.7 Cells

• Jung YY
• Hong JT
• Han SB
• Park YH
• Son DJ

• KMID: 2132707
• DOI: http://doi.org/10.4110/in.2015.15.6.325

Abstract

Inflammation is the basis of severe acute and chronic diseases. This study investigated the anti-inflammatory property of a crude methanol extract (MeOH-ex) and the solvent fractions of Ixeris dentata Nakai (IDN) in LPS-stimulated murine macrophage-like cell line RAW264.7. Here, we showed that the ethyl acetate fraction (EtOAc-fr) had the most potent inhibitory activity on LPS-induced nitric oxide (NO) production among the tested samples, i.e., IDN MeOH-ex and the three different solvent fractions (chloroform, n-hexane, and EtOAc). We further found that the EtOAc-fr significantly inhibited LPS-induced prostaglandin PGE2 (PGE2) generation in RAW264.7 cells. Furthermore, the treatment with EtOAc-fr effectively suppressed the expression of inducible NO synthase (iNOS) and cyclooxygenase 2 (COX-2). These results suggest that the EtOAc-fr of IDN MeOH-ex exhibits an anti-inflammatory activity in vitro by inhibiting LPS-induced NO production and PGE2 generation via suppression of iNOS and COX-2 expression.

Keyword

Ixeris dentate Nakai; Inflammation; Nitric oxide; Prostaglandin E2; iNOS; COX-2

MeSH Terms

Asteraceae*
Cell Line
Chronic Disease
Cyclooxygenase 2
Dinoprostone*
Inflammation
Methanol
Nitric Oxide Synthase
Nitric Oxide*
Cyclooxygenase 2
Dinoprostone
Methanol
Nitric Oxide
Nitric Oxide Synthase

Figure

• 

  Figure 1 The effect of a crude methanol extract and solvent fractions of Ixeris dentata Nakai (IDN) on nitric oxide production in LPS-stimulated RAW264.7 cells. Cells were treated with a range of concentrations of (A) IDN crude methanol extract (MeOH-ex), (B) normal hexane fraction (n-hexane-fr), (C) chloroform fraction (CHCl3-fr), and (D) ethyl acetate fraction (EtOAcfr) or vehicle (DMSO, white and black bars) for 24 h, as presented in the graphs. The production of nitric oxide (NO) in cells stimulated with 1 µg/mL of LPS was determined. Data are expressed as mean±SEM of three individual experiments with triplicate of each experiment. #p<0.05 vs. normal control, and *p<0.05 vs. vehicle-treated control.

• 

  Figure 2 The effect of a crude methanol extract and solvent fractions of Ixeris dentata Nakai (IDN) on prostaglandin E2 generation in LPS-stimulated RAW264.7 cells. Cells were treated with a range of concentrations of (A) IDN crude methanol extract (MeOH-ex), (B) normal hexane fraction (n-hexane-fr), (C) chloroform fraction (CHCl3-fr), and (D) ethyl acetate fraction (EtOAcfr) or vehicle (DMSO, white and black bars) for 24 h, as presented in the graphs. The generation of prostaglandin E2 (PGE2) in cells stimulated by 1 µg/mL of LPS was determined. Data are expressed as mean±SEM of three separated experiments with triplicate of each experiment. #p<0.05 vs. normal control, and *p<0.05 vs. vehicle-treated control.

• 

  Figure 3 The effect of ethyl acetate fraction (EtOAc-fr) of Ixeris dentata Nakai (IDN) crude methanol extract on the expression of iNOS and COX-2, and viability of RAW264.7 cells. Cells were treated with a range of concentrations of EtOAc-fr of MeOH-ex for 24 h. (A) The protein expression of iNOS and COX-2 were determined using western blot analysis. Blots were quantitated by Image J software. The graphs show the relative expression level of (B) iNOS and (C) COX-2 normalized to β-actin levels. Cell morphological changes (D) and viability (E) after treatment with EtOAc-fr or vehicle (DMSO) for 24 h were examined, and the results are expressed as percentages relative to the vehicle (DMSO)-treated control (white bar). Data are expressed as mean±SEM of three separated experiments with triplicate of each experiment. #p<0.05 vs. normal control, and *p<0.05 vs. vehicle-treated control.

Reference

1. Guzik TJ, Korbut R, mek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol. 2003; 54:469–487.

2. Lee TH, Song HJ, Park CS. Role of inflammasome activation in development and exacerbation of asthma. Asia Pac Allergy. 2014; 4:187–196.

3. Selmi C, Generali E, Massarotti M, Bianchi G, Scire CA. New treatments for inflammatory rheumatic disease. Immunol Res. 2014; 60:277–288.

4. Su X, Federoff HJ. Immune responses in Parkinsons disease: interplay between central and peripheral immune systems. Biomed Res Int. 2014; 2014:275178.

5. Zhiqin W, Palaniappan S, Raja Ali RA. Inflammatory Bowel Disease-related colorectal cancer in the Asia-Pacific Region: Past, Present, and Future. Intest Res. 2014; 12:194–204.

6. Iwakiri Y, Kim MY. Nitric oxide in liver diseases. Trends Pharmacol Sci. 2015; 36:524–536.

7. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011; 31:986–1000.

8. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol. 2002; 23:144–150.

9. Ahn EM, Bang MH, Song MC, Park MH, Kim HY, Kwon BM, Baek NI. Cytotoxic and ACAT-inhibitory sesquiterpene lactones from the root of Ixeris dentata forma albiflora. Arch Pharm Res. 2006; 29:937–941.

10. Oh SH, Sung TH, Kim MR. Ixeris dentata extract maintains glutathione concentrations in mouse brain tissue under oxidative stress induced by kainic acid. J Med Food. 2003; 6:353–358.

11. Lee HY, Lee GH, Kim HK, Kim SH, Park K, Chae HJ, Kim HR. Ixeris dentata-induced regulation of amylase synthesis and secretion in glucose-treated human salivary gland cells. Food Chem Toxicol. 2013; 62:739–749.

12. Kim DS, Ko JH, Jeon YD, Han YH, Kim HJ, Poudel A, Jung HJ, Ku SK, Kim SJ, Park SH, Park JH, Choi BM, Park SJ, Um JY, Hong SH. Ixeris dentata NAKAI reduces clinical score and HIF-1 expression in experimental colitis in mice. Evid Based Complement Alternat Med. 2013; 2013:671281.

13. Kim SB, Kang OH, Joung DK, Mun SH, Seo YS, Cha MR, Ryu SY, Shin DW, Kwon DY. Anti-inflammatory effects of tectroside on UVB-induced HaCaT cells. Int J Mol Med. 2013; 31:1471–1476.

14. Yi JM, Hong SH, Lee HJ, Won JH, Kim JM, Jeong DM, Baek SH, Lim JP, Kim HM. Ixeris dentata green sap inhibits both compound 48/80-induced aanaphylaxis-like response and IgE-mediated anaphylactic response in murine model. Biol Pharm Bull. 2002; 25:5–9.

15. Park EK, Sung JH, Trinh HT, Bae EA, Yun HK, Hong SS, Kim DH. Lactic acid bacterial fermentation increases the antiallergic effects of Ixeris dentata. J Microbiol Biotechnol. 2008; 18:308–313.

16. Jeon YD, Kee JY, Kim DS, Han YH, Kim SH, Kim SJ, Hong SH. Effects of Ixeris dentata water extract and caffeic acid on allergic inflammation in vivo and in vitro. BMC Complement Altern Med. 2015; 15:196.

17. Cha MR, Choi YH, Choi CW, Yoo DS, Kim YS, Choi SU, Kim YH, Ryu SY. New guaiane sesquiterpene lactones from Ixeris dentata. Planta Med. 2011; 77:380–382.

18. Karki S, Park HJ, Nugroho A, Kim EJ, Jung HA, Choi JS. Quantification of major compounds from Ixeris dentata, Ixeris dentata Var. albiflora, and Ixeris sonchifolia and their comparative anti-inflammatory activity in lipopolysaccharidestimulated RAW 2647 cells. J Med Food. 2015; 18:83–94.

19. Park S, Nhiem NX, Lee TH, Kim N, Kim SY, Chae HJ, Kim SH. Isolation of two new bioactive sesquiterpene lactone glycosides from the roots of Ixeris dentata. Bioorg Med Chem Lett. 2015; 25:4562–4566.

20. Nath J, Powledge A. Modulation of human neutrophil inflammatory responses by nitric oxide: studies in unprimed and LPS-primed cells. J Leukoc Biol. 1997; 62:805–816.

21. Son DJ, Ha SJ, Song HS, Lim Y, Yun YP, Lee JW, Moon DC, Park YH, Park BS, Song MJ, Hong JT. Melittin inhibits vascular smooth muscle cell proliferation through induction of apoptosis via suppression of nuclear factor-kappaB and Akt activation and enhancement of apoptotic protein expression. J Pharmacol Exp Ther. 2006; 317:627–634.

22. Ban JO, Yuk DY, Woo KS, Kim TM, Lee US, Jeong HS, Kim DJ, Chung YB, Hwang BY, Oh KW, Hong JT. Inhibition of cell growth and induction of apoptosis via inactivation of NF-kappaB by a sulfurcompound isolated from garlic in human colon cancer cells. J Pharmacol Sci. 2007; 104:374–383.

23. Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 2005; 4:281–286.

24. van Hoogmoed LM, Harmon FA, Stanley S, White J, Snyder J. In vitro investigation of the interaction between nitric oxide and cyclo-oxygenase activity in equine ventral colon smooth muscle. Equine Vet J. 2002; 34:510–515.

25. Baker RG, Hayden MS, Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell Metab. 2011; 13:11–22.